"President Shalala," he wrote, "I hope that you would agree--contrary to Dr. Goldschmidt's views that disciplining researchers for failing to disclose conflicts of interest is merely a political issue--that enforcing federal conflict of interest policy involves ethical and legal issues that ensure taxpayer trust."
In response to the letter, Grassley asked her to provide "all emails and communications by Dr. Goldschmidt," regarding Nemeroff's conflicts of interest and Nemeroff's work and/or grants with the NIH, and "all emails and communications by Dr. Nemeroff," regarding the same, along with all conflict of interest forms filed by Nemeroff with UM.
Money Laundering Operation
Dr Daniel Carlat, author of the Carlat Psychiatry Blog, and the new book, "Unhinged: the Trouble With Psychiatry," explains that "much of the continuing medical education (CME) industry in the United States is a legalized money laundering operation," in a June 10, 2008 blog.
"Rather than paying doctors directly to give accredited CME courses (which is illegal), drug companies pay third party companies to create the courses," he says. "The checks are actually written by the education company, but the ultimate source is clearly the sponsoring pharmaceutical company."
The Harvard scandal represents the "perfect storm" of the CME industry money laundering operation, Carlat reported on his blog.
It's clear that "the majority of money received by these doctors did not come directly from drug companies, but indirectly from various third party companies," he says. "And this is likely the key to the mystery of why the doctors assumed they could ethically hide these payments."
After going through the list of payments posted in the Congressional Record, Carlat found it appeared that "the vast majority of the money eventually reported by the Harvard Trio, a combined $4.2 million over 7 years, was drug company money that was laundered and processed to seem like it wasn't drug company money."
"The
most glaring example," he says, "comes from Dr. Wilens
disclosures."
Next Page 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).